Strongbridge Biopharma (SBBP) Announces Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV (levoketoconazole) at ENDO 2021 Meetings
Go back to Strongbridge Biopharma (SBBP) Announces Detailed Results from Pivotal Phase 3 LOGICS Study of RECORLEV (levoketoconazole) at ENDO 2021 Meetings(NASDAQ: SBBP) | Delayed: 2.00 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.00 | 52 Week High | $7.99 | |||
Open | $0.11 | 52 Week Low | $3.30 | |||
Day High | $2.00 | P/E | N/A | |||
Day Low | $2.00 | EPS | $0.00 | |||
Volume | 21,283,258 |